Showing results (1511-1520 of 6,159) with videos related to
Sort By:
Pageof 616
Nature Medicine|July 9, 2026
Biological aging clocks in health and diseaseTony Wyss-Coray, Eric J TopolNature Medicine|July 9, 2026
KRAS-G12D inhibitor HRS-4642 plus chemotherapy in advanced KRASG12D-mutant pancreatic cancer: a phase 1b/2 trialJiujie Cui, Kuirong Jiang, Wei Li, et al.Nature Medicine|June 26, 2026
Re-administration of AAV-mediated gene therapy for OTOF-related deafness: a single-arm trialXintai Fan, Longlong Zhang, Ziwen Gao, et al.Nature Medicine|June 26, 2026
Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trialPeter C Kahr, Fabian Aus dem Siepen, Olivier Lairez, et al.Nature Medicine|July 27, 2026
Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALSXiming Ran, Joanne Wuu, Zhaohui S Qin, et al.Nature Medicine|July 22, 2026
FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trialAdam D Cohen, Joshua Richter, Suzanne Trudel, et al.Nature Medicine|July 15, 2026
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trialTommaso Croese, Catherine J Mummery, Noa Bregman, et al.Nature Medicine|July 15, 2026
Oligonucleotide-siRNA conjugate for SOD1 amyotrophic lateral sclerosis: a phase 1 trialWeiqi Chen, Lingling Jiang, Chunling Duan, et al.Nature Medicine|July 28, 2026
Global economic burden of depression in 154 countries from 2025 to 2050Zhong Cao, Yuheng Luo, Lirui Jiao, et al.Nature Medicine|July 28, 2026
Integrated care pathway in individuals with Long COVID: STIMULATE-ICP, a cluster-randomized, phase 3 trialPageof 616